For Investors

Looking for potential investors.....

BioImaginix is an AI-powered biotech start-up working towards developing DL-based diagnostics platforms, drug discovery and design, and healthcare tools.

Diagnostic Platform: 

We have developed two DL-based diagnostics platforms: 

1. MRI-based Alzheimer’s disease detection

2. GI-Track imaging 

Both technologies are ready for testing on patients. 

Drug Discovery and Design:

AI-powered drug discovery is rapidly evolving. By 2025, it was projected that 30% of new drugs would be discovered using AI. We are developing drugs for Glioblastoma Multiforme, one of the deadliest brain tumors with no appropriate treatment and a very dismal survival record (~14 months). Target has been decided. We intend to develop both peptide/antibody-based biologics and small molecules.

AI-powered Healthcare Tools:

 BioImaginix intends to serve the healthcare industry by developing AI-powered tools like:

• AI-powered clinical decision support (CDS) tools

• Disease management: Improved diagnostics and prognostics

• Hospital Management and cost reduction

• AI-powered patient monitoring, personalized care, and personalized medicine.